絞り込み

16644

広告

子どもを早産 親どうしがアプリを使い交流 悩みなど相談 (NHK)

早産などで産まれた赤ちゃんの親どうしが、自宅にいながら交流できる機会をつくろうと、当事者たちがスマートフォンなどのアプリを使った対面式の交流会に取り組んでいます...

  1. 中国全土に新型肺炎広がる 春節祝賀行事を...
  2. 庁舎内のレジ袋削減へ実証実験 経産省など...
  3. iPS細胞で膝関節治療 京大・臨床研究計...
  4. [企業] RocheのPD-L1抗体テセ...

ニュース一覧

3414件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Request for an Andexxa Value Analysis.

Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan - Insight From the ANAFIE (All Nippon AF In Elderly) Registry.

Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.

Post-Renal Biopsy Acute Kidney Injury and Page Kidney from Intra-Renal Hematoma Aggravated by Reversible Contrast-Induced Nephropathy Following Renal Arterial Embolization.

[Pharmaco-utilization and outcomes in patients treated with oral anticoagulants from 2014 to 2015: evidences from administrative databases of the Romagna Local Health Unit].

[Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease].

A comprehensive evaluation of apixaban in the treatment of venous thromboembolism.

Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study.

Ischemic Stroke with Protein S Deficiency Treated by Apixaban.

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.

Bleeding in anticoagulated patients with atrial fibrillation: practical considerations.

Pain in the hip: Spontaneous retroperitoneal hemorrhage in an elderly patient on apixaban.

Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.

Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.

Rivaroxaban Versus Apixaban in Nonvalvular Atrial Fibrillation Patients with End-Stage Renal Disease or Receiving Dialysis.

The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding.

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.

Temporal Trends in the Practice Pattern for Venous Thromboembolism in Japan: Insight From JROAD-DPC.

A Systematic Review of Network Meta-Analyses and Real-World Evidence Comparing Apixaban and Rivaroxaban in Nonvalvular Atrial Fibrillation.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります